184 related articles for article (PubMed ID: 17299010)
1. Bisphosphonate-induced osteonecrosis of the jaw.
Krueger CD; West PM; Sargent M; Lodolce AE; Pickard AS
Ann Pharmacother; 2007 Feb; 41(2):276-84. PubMed ID: 17299010
[TBL] [Abstract][Full Text] [Related]
2. Antiresorptive and anti-angiogenic drug therapy in the pediatric population with reference to medication-related osteonecrosis of the jaw.
McLaurin WS; Francisco BJ; Hooker KJ; Sheshashayee N; Khan MTF; Triana RR; Rao MB; Pressey JG; Krishnan DG
Int J Oral Maxillofac Surg; 2024 Jun; 53(6):496-502. PubMed ID: 38030483
[TBL] [Abstract][Full Text] [Related]
3. Bisphosphonate induced osteonecrosis of jaw in breast cancer patients: A systematic review.
Varun B; Sivakumar T; Nair BJ; Joseph AP
J Oral Maxillofac Pathol; 2012 May; 16(2):210-4. PubMed ID: 22923892
[TBL] [Abstract][Full Text] [Related]
4. Pulp and periapical disease as a risk factor for osteonecrosis of the jaw: a national cohort-based study in Korea.
Baek HJ; Lee H; Lee JR; Park JH; Kim KS; Kwoen MJ; Lee TY; Kim JW; Lee HJ
J Periodontal Implant Sci; 2024 Apr; 54(2):65-74. PubMed ID: 37524381
[TBL] [Abstract][Full Text] [Related]
5. Removal of pamidronate from bone in rats using systemic and local chelation.
Howie RN; Bhattacharyya M; Salama ME; Refaey ME; Isales C; Borke J; Daoudi A; Medani F; Elsalanty ME
Arch Oral Biol; 2015 Dec; 60(12):1699-707. PubMed ID: 26431826
[TBL] [Abstract][Full Text] [Related]
6. Bisphosphonate associated osteonecrosis of the jaw: an update on pathophysiology, risk factors, and treatment.
Rasmusson L; Abtahi J
Int J Dent; 2014; 2014():471035. PubMed ID: 25254048
[TBL] [Abstract][Full Text] [Related]
7. Osteonecrosis of the Jaw Associated with Bisphosphonates Infusion for Treatment of Plasma Cell Myeloma-A Retrospective Observational Study of Northern Portuguese Population.
Ferreira SS; Amaral JBD; Pacheco JJ; Salazar F; Monteiro L
J Clin Med; 2024 May; 13(9):. PubMed ID: 38731207
[No Abstract] [Full Text] [Related]
8. Bisphosphonate related osteonecrosis of the jaw: a study of 18 cases associated with fungal infection.
Aftimos V; Zeinoun T; Bou Tayeh R; Aftimos G
Int J Dent; 2014; 2014():869067. PubMed ID: 24696686
[TBL] [Abstract][Full Text] [Related]
9. Closure of an open wound associated with bisphosphonate-related osteonecrosis of the jaw in a breast cancer patient.
Soolari N; Soolari A
Open Dent J; 2011; 5():163-7. PubMed ID: 22135700
[TBL] [Abstract][Full Text] [Related]
10. Influence of the use of bisphosphonates on the development of postextraction sequelae: scoping review with mapping evidence of in vivo studies.
Dias MO; Menezes GPR; Tavares FOM; Leite KLF; Tenório JDR; Esteves JC; Prado R; Maia LC
J Dent; 2024 May; ():105051. PubMed ID: 38763386
[TBL] [Abstract][Full Text] [Related]
11. Multiple systemic diseases complicated by bisphosphonate osteonecrosis: a case report.
Carini F; Barbano L; Saggese V; Monai D; Porcaro G
Ann Stomatol (Roma); 2012 Apr; 3(2 Suppl):32-6. PubMed ID: 23285320
[TBL] [Abstract][Full Text] [Related]
12. Occurrence of bisphosphonate-associated osteonecrosis of the jaws in individuals with rheumatoid arthritis - a systematic review.
Tenório JR; Estanho D; Silva LS; Pintor AV; Magno MB; Cavalcante IL; Andrade BA; Maia LC
Med Oral Patol Oral Cir Bucal; 2023 Dec; 29(3):e390-7. PubMed ID: 38150601
[TBL] [Abstract][Full Text] [Related]
13. [Adverse drug reactions in the oral cavity].
Böttiger Y; Ekenstråle E
Lakartidningen; 2024 Mar; 121():. PubMed ID: 38470273
[TBL] [Abstract][Full Text] [Related]
14. A case of variegate porphyria in association with coeliac disease and bisphosphonate associated dental osteonecrosis.
Ogundipe OA
J Clin Med Res; 2009 Dec; 1(5):292-6. PubMed ID: 22481993
[TBL] [Abstract][Full Text] [Related]
15. Improving Bisphosphonate Infusion Monitoring at Haematology Medical Day Unit.
Ong MWS; Jones L
BMJ Qual Improv Rep; 2017; 6(1):. PubMed ID: 28469896
[TBL] [Abstract][Full Text] [Related]
16. Osteonecrosis caused by Bisphosphonates: a clinical case.
Spinelli D; DE Vico G; Bonino M; Barlattani A; Bollero P; Barlattani A
Oral Implantol (Rome); 2009 Oct; 2(4):26-34. PubMed ID: 23285372
[TBL] [Abstract][Full Text] [Related]
17. Influence of antiresorptive/antiangiogenic therapy on changes in periodontal and oral tissue structures: a histomorphometrical analysis in rats.
Ramanauskaite A; Mangold K; Padhye N; Obreja K; Borschert F; Dahmer I; Schwarz F
Clin Oral Investig; 2023 Dec; 27(12):7695-7704. PubMed ID: 37910240
[TBL] [Abstract][Full Text] [Related]
18. Morroniside Inhibits Inflammatory Bone Loss through the TRAF6-Mediated NF-κB/MAPK Signalling Pathway.
Xiao J; Han Q; Yu Z; Liu M; Sun J; Wu M; Yin H; Fu J; Guo Y; Wang L; Ma Y
Pharmaceuticals (Basel); 2023 Oct; 16(10):. PubMed ID: 37895909
[TBL] [Abstract][Full Text] [Related]
19. Fabrication of Membrane Sensitive Electrodes for the Validated Electrochemical Quantification of Anti-Osteoporotic Drug Residues in Pharmaceutical Industrial Wastewater.
Abdel-Gawad SA; Afzal O; Arab HH; Alabbas AB; Alqarni AM
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443681
[TBL] [Abstract][Full Text] [Related]
20. Oral care and the use of bone-targeted agents in patients with metastatic cancers: A practical guide for dental surgeons and oncologists.
Kuchuk I; Mazzarello S; Butterfield K; Appleton A; Addison CL; Clemons M
J Bone Oncol; 2013 Feb; 2(1):38-46. PubMed ID: 26909271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
